Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways
- 24 June 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 334 (1), 193-198
- https://doi.org/10.1016/j.bbrc.2005.06.065
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthNature Medicine, 2001
- Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.2001
- Dendritic cell lineage, plasticity and cross-regulationNature Immunology, 2001
- VEGF as a Mediator of Tumor-Associated ImmunodeficiencyImmunologic Research, 2001
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- Immunobiology of Dendritic CellsAnnual Review of Immunology, 2000
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Angiogenesis and metastasisEuropean Journal Of Cancer, 1996
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Dendritic Cells in Antitumor Immune ResponsesCellular Immunology, 1996